Header cover image

New Zealand (NZX) Pharma Industry Analysis

UpdatedMar 27, 2023
DataAggregated Company Financials
  • 7D-1.4%
  • 3M-2.8%
  • 1Y-13.0%
  • YTD-5.8%

Over the last 7 days, the Pharma industry has dropped 1.4%, driven by a pullback from AFT Pharmaceuticals of 2.8%. On the other hand Rua Bioscience is actually up 10%. Overall the industry is down 13% in 12 months. Earnings are forecast to grow by 24% annually.

Industry Valuation and Performance

Has the New Zealand Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 27 Mar 2023NZ$481.6mNZ$150.7mNZ$1.1m21.2x440.4x3.2x
Wed, 22 Feb 2023NZ$497.7mNZ$153.3mNZ$1.2m21.8x411.7x3.2x
Fri, 20 Jan 2023NZ$522.1mNZ$153.3mNZ$1.2m23.4x431.9x3.4x
Sun, 18 Dec 2022NZ$502.4mNZ$153.3mNZ$1.2m22.3x415.6x3.3x
Tue, 15 Nov 2022NZ$505.8mNZ$143.0mNZ$3.9m19.3x130x3.5x
Thu, 13 Oct 2022NZ$490.8mNZ$143.0mNZ$3.9m17.9x126.1x3.4x
Sat, 10 Sep 2022NZ$512.6mNZ$142.3mNZ$8.0m18.5x64.3x3.6x
Mon, 08 Aug 2022NZ$537.9mNZ$141.0mNZ$9.7m19.1x55.4x3.8x
Wed, 06 Jul 2022NZ$525.7mNZ$141.0mNZ$9.7m18.8x54.1x3.7x
Fri, 03 Jun 2022NZ$594.1mNZ$140.7mNZ$10.1m22.4x58.7x4.2x
Sun, 01 May 2022NZ$543.3mNZ$130.2mNZ$920.3k35.4x590.3x4.2x
Tue, 29 Mar 2022NZ$540.4mNZ$130.2mNZ$2.2m34.8x248.2x4.2x
Thu, 24 Feb 2022NZ$592.5mNZ$129.0m-NZ$95,598.00n/a-6197.9x4.6x
Sat, 22 Jan 2022NZ$647.6mNZ$129.0m-NZ$95,598.00n/a-6774.2x5x
Mon, 20 Dec 2021NZ$636.2mNZ$129.0m-NZ$95,598.0041.3x-6655x4.9x
Wed, 17 Nov 2021NZ$701.5mNZ$124.1m-NZ$281,598.00n/a-2491.1x5.7x
Fri, 15 Oct 2021NZ$617.7mNZ$124.1m-NZ$281,598.0096.4x-2193.7x5x
Sun, 12 Sep 2021NZ$645.5mNZ$124.1m-NZ$281,598.00103x-2292.2x5.2x
Tue, 10 Aug 2021NZ$666.3mNZ$124.7m-NZ$281,598.00108.4x-2366.2x5.3x
Mon, 03 May 2021NZ$664.2mNZ$124.7mNZ$307.1k91.1x2162.7x5.3x
Thu, 04 Feb 2021NZ$770.9mNZ$122.2m-NZ$823,103.0086.9x-936.5x6.3x
Sun, 08 Nov 2020NZ$786.4mNZ$119.7m-NZ$1,636,586.00111.7x-480.5x6.6x
Sat, 01 Aug 2020NZ$628.9mNZ$117.8mNZ$6.3m57.1x100.1x5.3x
Tue, 05 May 2020NZ$549.1mNZ$116.5mNZ$10.8m45.4x50.8x4.7x
Price to Earnings Ratio


Total Market Cap: NZ$460.8mTotal Earnings: NZ$10.8mTotal Revenue: NZ$116.5mTotal Market Cap vs Earnings and Revenue0%0%0%
New Zealand Pharma Industry Price to Earnings3Y Average -723.4x202120222023
Current Industry PE
  • Investors are optimistic on the New Zealander Pharmaceuticals industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 440x which is higher than its 3-year average PE of -724x.
  • The 3-year average PS ratio of 4.8x is higher than the industry's current PS ratio of 3.2x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have declined 53% per year over the last three years.
  • Meanwhile revenues for these companies have grown 9.0% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the New Zealand Healthcare industry?

NZ Market-1.14%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
RUA Rua BioscienceNZ$0.2010.5%
CBD CannasouthNZ$0.295.4%
GFI Greenfern IndustriesNZ$0.0921.1%
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News










AFT Pharmaceuticals







Rua Bioscience







Greenfern Industries